Insider Transactions in Q1 2023 at Iovance Biotherapeutics, Inc. (IOVA)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 17
2023
|
Frederick G Vogt Interim CEO & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
36,441
-42.71%
|
$218,646
$6.43 P/Share
|
|
Jan 17
2023
|
Frederick G Vogt Interim CEO & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
83,325
+49.41%
|
-
|
|
Jan 17
2023
|
Igor Bilinsky Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,671
-16.08%
|
$28,026
$6.43 P/Share
|
|
Jan 17
2023
|
Igor Bilinsky Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,248
+27.91%
|
-
|
|
Jan 17
2023
|
Finckenstein Friedrich Graf Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,678
-14.26%
|
$28,068
$6.43 P/Share
|
|
Jan 17
2023
|
Finckenstein Friedrich Graf Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,248
+25.54%
|
-
|
|
Jan 03
2023
|
Finckenstein Friedrich Graf Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,023
-33.84%
|
$66,138
$6.11 P/Share
|
|
Jan 03
2023
|
Finckenstein Friedrich Graf Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,690
+37.68%
|
-
|
|
Jan 03
2023
|
Jean Marc Bellemin Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,553
-37.22%
|
$63,318
$6.11 P/Share
|
|
Jan 03
2023
|
Jean Marc Bellemin Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,850
+39.93%
|
-
|
|
Jan 03
2023
|
Igor Bilinsky Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,553
-37.22%
|
$63,318
$6.11 P/Share
|
|
Jan 03
2023
|
Igor Bilinsky Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,850
+39.93%
|
-
|